Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

NCT02214134 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.

NCT NCT02214134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Phase
Observational
Overall status
Completed
Start date
May 22, 2015
Completion date
May 12, 2021
Enrollment
539 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

any stage of any thymic malignancy, any stage of lung cancer (any histotype), any stage of malignant pleural mesothelioma